Cargando…
Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study
SIMPLE SUMMARY: In this study, we examined the prescription patterns and pharmaceutical costs for treatments of multiple myeloma (MM) in Catalonia’s public healthcare system over the past decade. MM is a complex and costly disease for which substantial pharmacological innovation has recently been in...
Autores principales: | Garrido-Alejos, Gemma, Saborit-Canals, Guillem, Guarga, Laura, de Pando, Thais, Umbria, Miriam, Oriol, Albert, Feliu, Anna, Pontes, Caridad, Vallano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670024/ https://www.ncbi.nlm.nih.gov/pubmed/38001598 http://dx.doi.org/10.3390/cancers15225338 |
Ejemplares similares
-
Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain)
por: Gasol, Montse, et al.
Publicado: (2022) -
Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2023) -
Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival: A Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2022) -
Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)
por: Guarga, Laura, et al.
Publicado: (2019) -
Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study
por: Brunet, Eduard, et al.
Publicado: (2022)